U.S. Markets closed

Synairgen plc (SNG.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
165.000.00 (0.00%)
At close: 5:07PM BST
Sign in to post a message.
  • M
    Miljan
    https://www.synairgen.com/wp-content/uploads/2020/09/200908-SG015-Press-Release-Final.pdf

    Very close to a deal with big pharma IMHO. Doubled my position today.
    Bullish
  • S
    Sourdough
    I’m in USA. Got in yesterday with 1k shares.
    I haven’t found much news since 20 July.

    Could anyone enlighten me as to what is going on with more testing, data analysis, approval, etc.

    Thank you.
  • F
    Frank
    Dr. Yo (he covers Cytodyn and Relief T) said that he would soon cover Synairgen.
  • K
    Kapil Khanna
    Venrock Healthcare Capital Partners Management is now Synairgen's second-biggest institutional shareholder, now owning 6.1% of the stock

    https://markets.ft.com/data/announce/full?dockey=1323-14647744-45RPG12AME2B3KK45J9EQ5NJH9
    The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
    The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
    markets.ft.com
    Bullish
  • F
    Frank
    Latest comment here is 2 days old. That means this stock is completely out of any pump here. US is not aware yet about the worlds best Covid-19 results from any clinical trial.

    Not any other company including al the big Pharma had yet such great effect in a Covid-19 randomized placebo controlled trial.

    This is really crazy, some OTC Covid 19 stocks have a market capitalization of some billions and this one has 300 Mio and is ahead of the race.

    Only because it is a British company....( which are much more reliable than US OTC from my experience).
  • R
    RowkinsCapital.com
    There will not be much movement till any new news leaks out. the stock may peak and slip slowly till then.

    Their Interferon inhaled treatment is cheap and simple to administer. The team are very understated. Which is good!!
  • a
    allostatic_loaf
    $SYGGF mentioned in New York Post along side Remdesivir, Dexamethasone, and RLF-100 ($RLFTF)

    https://nypost.com/article/potential-covid-19-treatments/
    Here’s a list of the most promising treatments and potential vaccines for SARS-CoV-2, the virus that causes COVID-19.
    Here’s a list of the most promising treatments and potential vaccines for SARS-CoV-2, the virus that causes COVID-19.
    nypost.com
  • M
    Matthew
    It went from 34p to £2.24 but its £1.74 today it still only has a market cap of £266Million it should be 500 million i think it's still too cheap
  • R
    Rex
    Nice, congrats all! Check out $betrd - similar interferon treatment. About to kick off Phase II study in Australia. Low market cap and float.
  • y
    yoninadi
    Not much news from Synairgen .
  • F
    Frank
    These are the best conditions for a great advances of the stock price soon:

    1) Worldwide best clinical results from a randomized placebo-controlled trial against Covid-19. see HP first page:

    https://www.synairgen.com

    https://www.bbc.com/news/health-53467022

    2) in total 1 post here in 24 hours because still undetected by the US. No hype, no pump (like in so many US stocks)

    3) ALMOST undetected - because smart money is accumulating here: US Biotech Fond is buying since days now. Today this Fond had to announce that they passed the 5% treshold: https://www.lse.co.uk/rns/SNG/holdings-in-company-xsvyv889juv8cel.html

    Not realized in the US because it is from England....

    This will go up from here as it is not discover yet by the US. Look at the market capitalization about 300 Mio USD, but it has by far the best Covid-19 results - globally.
  • F
    Frank
    Absolute zero interest here, while the odds are so clear here for the coming profit:Just have a look to the RNS (obligatory notice to the London Stock Exchange when exceeding a certain number of shares....)Over the last days, several Fonds and Ventura capital have all increased their holding. Takes only 2-3 minutes to open the RNS and verify these buys: https://www.lse.co.uk/rns/SNGThe number of freely available shares get smaller and smaller every day- check almost every day a RNS that a Fond has increased its position (no sells at all).No doubt: stockprice must advance soon. Synairgen had so far by far the best clinical results from a Covid-19 randomized placebo-controlled trial.The one and only reason why this has not been exploded yet: it is British and not US. But neither the virus nor the drug or money stop at borders.Among the buyers also #$%$ Fond (Venrock capital 6 % and Venrock managers with more than 8%) from New York. The smart US money have already found Synairgen - the small investors not yet.
    Synairgen Regulatory News. Live SNG RNS. Regulatory News Articles for Synairgen Plc Ord 1P
    Synairgen Regulatory News. Live SNG RNS. Regulatory News Articles for Synairgen Plc Ord 1P
    www.lse.co.uk
  • y
    yoninadi
    It appears that SNG.L is more successful than MRNA with a breakthrough of a medication that will “neutralize “ the COVID-19!
  • C
    Confucius
    How to trade in the States?
  • T
    TC666999
    Who go in early? I know i did - hopefully the results are confirmed and then T/O! Well done to LTH - its was a tough ride
    Bullish
  • j
    jon
    Im in Canada and could only buy SYGGF which is on the OTC (Grey market) It says it’s Synairgen PLC but not seeing any significant movement
  • G
    Grizzly Adams
    Leronlimab is next !
  • r
    ross
    Hopefully BSGM will have a pill form cure. This will have a long shelf life and no need to go to a hospital.
  • G
    Grizzly Adams
    Cydy is next
  • I
    IlyaB
    How do you invest from US? Which broker?